CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 713 enrolled
Drug / intervention
Retrainingbehavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01293799
NCT01293799N/ACompleted

Prevention of Peritonitis in Patients With Peritoneal Dialysis - Effects of Regular Follow-up of Patients´ Theoretical Knowledge and Practical Skills With Focus on Infection Prophylaxis

Sahlgrenska University Hospital·interventional·Posted Feb 11, 2011·Updated Dec 16, 2025

In Brief

A clinical study evaluating Retraining for Kidney Failure, Chronic and 2 related conditions. Completed, enrolled 713 participants across 1 site.

Detailed Summary

BACKGROUND: Peritonitis remains a significant problem in peritoneal dialysis (PD). It is the leading cause of technique failure, and contributes to mortality. The incidence is highest during the first year of treatment. Non-compliance with the PD protocol is shown to be an important risk factor for peritonitis. Reinforcement of knowledge and ability to perform PD therefore appears to be a possible way to reduce the incidence of peritonitis. This will be studied in The PEritonitis Prevention Study (PEPS). METHODS: The objective of this randomized, multi-centre investigation, which will include 750 new PD patients who can perform (PD) without assistance, is to evaluate if regular retraining can reduce the incidence of peritonitis, the technique-failure rate, and the hospitalisation days due to peritonitis compared with regular follow-up regimen. Patients in the intervention group will be tested by a PD-technique test and a questionnaire at regular intervals after PD-start and after every peritonitis episode with focus on infection prophylaxis. If needed, they will be retrained. The control group will be treated according to the routine of the center. The study is ongoing in Denmark, Norway, Sweden, Finland, Estonia, Latvia, the Netherlands, and the United Kingdom (UK). The study will go on for 6 years.

Study Details

Timeline

N/ACompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
First PostedFeb 11, 2011
Enrollment StartJan 1, 2010
Primary CompletionDec 1, 2012
Study CompletionDec 31, 2015
TodayJul 2, 2026
Enrollment to primary: 2.9 yearsPosted 15.4 years ago

Interventions

Retrainingbehavioral

Testing of the patients´ knowledge and retraining will be given if needed